Smaller Players Find Opportunity In Large Joints
Five companies control 95% of the market in hip and knee implants, creating an unfriendly environment for newcomers trying to grab a piece of their own. But economic and regulatory pressures are making things increasingly uncomfortable for the market leaders, giving hope to companies pushing new technologies and sales techniques.
You may also be interested in...
MicroPort’s Wright Bid Creates New Ortho Player
Wright Medical’s decision to sell its hip and knee business wasn’t entirely unexpected. The buyer, the Chinese company MicroPort, may have surprised some, but changes in orthopedics and the device industry as a whole could make such deals more common.
Large Joint Replacement Market: Set For A Rebound?
Beaten down by the great recession, the large joint arthroplasty market appears to be on the cusp of a turnaround, with several big players reporting encouraging Q4 and full-year 2012 results. A full recovery in this space is likely to take some time, but technology advances could help jumpstart the process, and there may be some interesting dynamics ahead in the patient-specific implant and robotic ortho device arenas.
Device/Diagnostics Quarterly Deal Statistics, Q3 2012
Device companies raised a total of $801 million in 2012’s third quarter, an 18% drop from Q2’s $977 million. Approximately $2.6 billion was spent on device acquisitions, exactly $2 billion less than Q2’s total. Diagnostic/research company financings totaled $484 million during Q3 2012, up from last quarter’s $336 million. And while diagnostic/research M&A activity was not as prolific as last quarter, tech transfer deals are seeing a resurgence.